EquityZen Growth Technology Fund LLC - Series 2274
Raised
$315K
Investors
18
Min Invest
$10,004
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2274 is a Delaware SPV filed by EquityZen Advisors LLC and Philip Haslett on 2026-05-15, raising $315K from 18 investors under Rule 506(b) and Section 3(c)(1). The offering carries a $10K minimum investment and is part of EquityZen's pre-IPO secondary market platform with over 1,800 related EDGAR entities.
This pre-IPO vehicle follows the standard EquityZen series SPV structure, utilizing the 506(b) private placement exemption with 3(c)(1) investment company exclusion. The $10K minimum is consistent with EquityZen's retail-accessible pre-IPO model, substantially lower than typical institutional secondaries which often require $250K+ commitments.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
